Massachusetts 2023-2024 Regular Session

Massachusetts House Bill H3629 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	1 of 1
2	2	HOUSE DOCKET, NO. 2799 FILED ON: 1/19/2023
3	3	HOUSE . . . . . . . . . . . . . . . No. 3629
4	4	The Commonwealth of Massachusetts
5	5	_________________
6	6	PRESENTED BY:
7	7	Marjorie C. Decker
8	8	_________________
9	9	To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
10	10	Court assembled:
11	11	The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
12	12	An Act relative to the prescription monitoring program.
13	13	_______________
14	14	PETITION OF:
15	15	NAME:DISTRICT/ADDRESS :DATE ADDED:Marjorie C. Decker25th Middlesex1/11/2023 1 of 2
16	16	HOUSE DOCKET, NO. 2799 FILED ON: 1/19/2023
17	17	HOUSE . . . . . . . . . . . . . . . No. 3629
18	18	By Representative Decker of Cambridge, a petition (accompanied by bill, House, No. 3629) of
19	19	Marjorie C. Decker relative to the administration of opioid maintenance treatment in the
20	20	prescription monitoring program. Public Health.
21	21	[SIMILAR MATTER FILED IN PREVIOUS SESSION
22	22	SEE HOUSE, NO. 2250 OF 2021-2022.]
23	23	The Commonwealth of Massachusetts
24	24	_______________
25	25	In the One Hundred and Ninety-Third General Court
26	26	(2023-2024)
27	27	_______________
28	28	An Act relative to the prescription monitoring program.
29	29	Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
30	30	of the same, as follows:
31	31	1 SECTION 1. Section 24A of chapter 94C of the General Laws, as appearing in the 2020
32	32	2Official Edition, is hereby amended by inserting after subsection (c) the following subsection:-
33	33	3 (c½) The department shall establish, by rule or regulation, a process by which to include
34	34	4information about the administration of opioid maintenance treatment in the prescription
35	35	5monitoring program, when the inclusion of such information does not conflict with state or
36	36	6federal privacy rules. The purpose of this subsection shall be to ensure that licensed professionals
37	37	7authorized to prescribe controlled substances receive information, through utilization of the
38	38	8prescription monitoring program, about an individual patient’s participation in opioid
39	39	9maintenance treatment prior to issuing a new prescription for an opioid substance other than the
40	40	10substance used for opioid maintenance treatment. 2 of 2
41	41	11 SECTION 2. Section 18 of chapter 111E of the General Laws, as appearing in the 2020
42	42	12Official Edition, is hereby amended by inserting after subsection (a) the following subsection:-
43	43	13 (a½) For each facility that is an opioid treatment program, as defined under 42 CFR Part
44	44	148, the facility shall present to each individual entering treatment a form that allows the individual
45	45	15to consent to the release of information, through the prescription monitoring program, about the
46	46	16administration of opioid maintenance treatment at the facility. Said consent form shall be
47	47	17accompanied by information clearly explaining that such consent is not required but is
48	48	18encouraged to improve coordination of services; and by information on how the individual may
49	49	19complete and return the form to the facility or to the department of public health if they elect to
50	50	20give such consent. A record of the individual’s election relative to this form shall be maintained
51	51	21by the facility as part of the record of treatment required by this section. The same form and
52	52	22information shall be presented to the individual upon their discharge from the facility.